Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Dr Ophelia Limited currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is assigned to ROBERTS, LEZAH, and is located in 1 distinct art unit.
ROBERTS, LEZAH is the busiest examiner, accounting for the pending office action. This matter represents the entirety of the company's active prosecution. The presence of only the distinct examiner and the art unit indicates a centralized prosecution profile at this time.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROBERTS, LEZAH | 1 | 48.6% | +35.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18575619 | FORMULATION FOR INCREASING HAIR GROWTH AND REDUCING HAIR THINNING | ROBERTS, LEZAH | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18575619 | FORMULATION FOR INCREASING HAIR GROWTH AND REDUCING HAIR THINNING | ROBERTS, LEZAH | 1612 | §103 | Final Rejection | — | Pending | Dec 29, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialDr Ophelia Limited has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Lezah Roberts has the most, with 1 of Dr Ophelia Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
